ArticleFrontiers in immunology2026

A novel clinical FIT model predicts prognosis of unresectable hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors therapy.

Minjun Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.